Stock Research: BRAIN Biotech

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

BRAIN Biotech

XTRA:BNN DE0005203947
1
  • Value
    39
  • Growth
    11
  • Safety
    Safety
    16
  • Combined
    6
  • Sentiment
    22
  • 360° View
    360° View
    1
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

BRAIN Biotech AG is a Germany-based company that supplies bio-based products and solutions for industrial processes. It operates in the nutrition, health, and environment industries. In the last fiscal year, the company had a market cap of $49 million, profits of $35 million, and revenue of $62 million with 325 employees.

more
Index
CDAX
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
39 12 29 21
Growth
11 55 53 33
Safety
Safety
16 9 16 10
Sentiment
22 46 54 31
360° View
360° View
1 7 12 11
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
97 89 85 70
Opinions Change
21 68 50 50
Pro Holdings
n/a 17 10 21
Market Pulse
17 33 54 26
Sentiment
22 46 54 31
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
39 12 29 21
Growth
11 55 53 33
Safety Safety
16 9 16 10
Combined
6 1 8 6
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
5 3 26 29
Price vs. Earnings (P/E)
80 73 64 39
Price vs. Book (P/B)
27 20 25 17
Dividend Yield
1 1 1 1
Value
39 12 29 21
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
20 80 72 72
Profit Growth
87 89 26 53
Capital Growth
10 35 92 6
Stock Returns
13 20 21 45
Growth
11 55 53 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
4 3 64 56
Refinancing
75 70 35 23
Liquidity
10 12 6 10
Safety Safety
16 9 16 10

Similar Stocks

Discover high‑ranked alternatives to BRAIN Biotech and broaden your portfolio horizons.

KSB

XTRA:KSB
Country: Germany
Industry: Industrial Machinery
Size: Medium
Full Stock Analysis

DWS

XTRA:DWS
Country: Germany
Industry: Asset Management & Custody
Size: Large
Full Stock Analysis

Commerzbank

XTRA:CBK
Country: Germany
Industry: Diversified Banks
Size: Medium
Full Stock Analysis

BMW

XTRA:BMW
Country: Germany
Industry: Automobile Manufacturers
Size: XX-Large
Full Stock Analysis

Frequently Asked
Questions

This is a highly risky stock investment proposition as all consolidated ranks are below-average. There are no compelling arguments to support this stock based on current information. It is not recommended for any investor profile. However, performance does change, so it could we worth keepin on a watchlist.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: